Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $1.17 billion. The enterprise value is $932.63 million.
Market Cap | 1.17B |
Enterprise Value | 932.63M |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025, before market open.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AUPH has 135.10 million shares outstanding. The number of shares has increased by 1.68% in one year.
Current Share Class | 135.10M |
Shares Outstanding | 135.10M |
Shares Change (YoY) | +1.68% |
Shares Change (QoQ) | -3.03% |
Owned by Insiders (%) | 2.07% |
Owned by Institutions (%) | 51.36% |
Float | 131.18M |
Valuation Ratios
The trailing PE ratio is 29.77 and the forward PE ratio is 12.59.
PE Ratio | 29.77 |
Forward PE | 12.59 |
PS Ratio | 4.54 |
Forward PS | 5.83 |
PB Ratio | 3.12 |
P/TBV Ratio | 3.37 |
P/FCF Ratio | 18.24 |
P/OCF Ratio | 18.16 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.06, with an EV/FCF ratio of 14.57.
EV / Earnings | 23.41 |
EV / Sales | 3.77 |
EV / EBITDA | 15.06 |
EV / EBIT | 21.96 |
EV / FCF | 14.57 |
Financial Position
The company has a current ratio of 5.93, with a Debt / Equity ratio of 0.22.
Current Ratio | 5.93 |
Quick Ratio | 5.16 |
Debt / Equity | 0.22 |
Debt / EBITDA | 1.24 |
Debt / FCF | 1.22 |
Interest Coverage | 9.19 |
Financial Efficiency
Return on equity (ROE) is 11.23% and return on invested capital (ROIC) is 6.06%.
Return on Equity (ROE) | 11.23% |
Return on Assets (ROA) | 5.20% |
Return on Invested Capital (ROIC) | 6.06% |
Return on Capital Employed (ROCE) | 9.73% |
Revenue Per Employee | $1.90M |
Profits Per Employee | $306,500 |
Employee Count | 130 |
Asset Turnover | 0.48 |
Inventory Turnover | 1.16 |
Taxes
In the past 12 months, AUPH has paid $1.96 million in taxes.
Income Tax | 1.96M |
Effective Tax Rate | 4.69% |
Stock Price Statistics
The stock price has increased by +56.81% in the last 52 weeks. The beta is 1.16, so AUPH's price volatility has been higher than the market average.
Beta (5Y) | 1.16 |
52-Week Price Change | +56.81% |
50-Day Moving Average | 8.08 |
200-Day Moving Average | 8.01 |
Relative Strength Index (RSI) | 66.20 |
Average Volume (20 Days) | 1,368,547 |
Short Selling Information
The latest short interest is 10.53 million, so 7.79% of the outstanding shares have been sold short.
Short Interest | 10.53M |
Short Previous Month | 10.50M |
Short % of Shares Out | 7.79% |
Short % of Float | 8.03% |
Short Ratio (days to cover) | 8.40 |
Income Statement
In the last 12 months, AUPH had revenue of $247.30 million and earned $39.85 million in profits. Earnings per share was $0.27.
Revenue | 247.30M |
Gross Profit | 197.25M |
Operating Income | 42.47M |
Pretax Income | -48.10M |
Net Income | 39.85M |
EBITDA | 61.92M |
EBIT | 42.47M |
Earnings Per Share (EPS) | $0.27 |
Balance Sheet
The company has $312.59 million in cash and $77.91 million in debt, giving a net cash position of $234.68 million or $1.74 per share.
Cash & Cash Equivalents | 312.59M |
Total Debt | 77.91M |
Net Cash | 234.68M |
Net Cash Per Share | $1.74 |
Equity (Book Value) | 350.19M |
Book Value Per Share | 2.54 |
Working Capital | 337.36M |
Cash Flow
In the last 12 months, operating cash flow was $64.29 million and capital expenditures -$286,000, giving a free cash flow of $64.00 million.
Operating Cash Flow | 64.29M |
Capital Expenditures | -286,000 |
Free Cash Flow | 64.00M |
FCF Per Share | $0.47 |
Margins
Gross margin is 79.76%, with operating and profit margins of 17.17% and 16.11%.
Gross Margin | 79.76% |
Operating Margin | 17.17% |
Pretax Margin | 16.91% |
Profit Margin | 16.11% |
EBITDA Margin | 25.04% |
EBIT Margin | 17.17% |
FCF Margin | 25.88% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.68% |
Shareholder Yield | -1.68% |
Earnings Yield | 3.41% |
FCF Yield | 5.48% |
Analyst Forecast
The average price target for AUPH is $11.50, which is 33.10% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $11.50 |
Price Target Difference | 33.10% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 12.52% |
EPS Growth Forecast (5Y) | 101.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 0.02:1.
Last Split Date | Oct 23, 2013 |
Split Type | Reverse |
Split Ratio | 0.02:1 |
Scores
AUPH has an Altman Z-Score of 2.86 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.86 |
Piotroski F-Score | 7 |